Fei Luo
Impact in
- Biochemistry top 10%
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Lipid metabolism and disorders 12
- Surgery 17
- Lipoproteins and Cardiovascular Health 12
- Cholesterol and Lipid Metabolism 6
- Co-authors
- Xiangping Li (10 shared papers)Avash Das (5 shared papers)Zhenfei Fang (18 shared papers)Guiyun Ruan (6 shared papers)Panyun Wu (9 shared papers)Ran Peng (3 shared papers)Yuan Guo (10 shared papers)Jingfei Chen (12 shared papers)
- Journals
- Lipids in Health and Disease (12 papers)Journal of Cellular and Molecular Medicine (4 papers)World Journal of Microbiology and Biotechnology (3 papers)International Journal of Cardiology (3 papers)Frontiers in Cardiovascular Medicine (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Fei Luo
105 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 124
- Biochemistry 54
- Endocrinology, Diabetes and Metabolism 144
- Epidemiology 234
- Cancer Research 83
- Cardiology and Cardiovascular Medicine 147
Countries citing papers authored by Fei Luo
This map shows the geographic impact of Fei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Luo more than expected).
Fields of papers citing papers by Fei Luo
This network shows the impact of papers produced by Fei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Luo. The network helps show where Fei Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 200 | |
| 2 | 2019 | 136 | |
| 3 | 2021 | 102 | |
| 4 | 2016 | 81 | |
| 5 | 2020 | 78 | |
| 6 | 2021 | 67 | |
| 7 | 2023 | 63 | |
| 8 | 2017 | 56 | |
| 9 | 2014 | 45 | |
| 10 | 2023 | 43 | |
| 11 | 2023 | 40 | |
| 12 | 2024 | 37 | |
| 13 | 2017 | 36 | |
| 14 | 2022 | 35 | |
| 15 | 2025 | 32 | |
| 16 | 2017 | 31 | |
| 17 | 2023 | 29 | |
| 18 | 2024 | 28 | |
| 19 | 2019 | 26 | |
| 20 | 2021 | 26 |
About Fei Luo
Fei Luo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Biochemistry, Spectroscopy and Cancer Research, having authored 113 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (12 papers), Lipid metabolism and disorders (12 papers), Cholesterol and Lipid Metabolism (6 papers), Molecular Sensors and Ion Detection (5 papers), Advanced Battery Materials and Technologies (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Geotechnical Engineering and Soil Stabilization (4 papers) and Luminescence Properties of Advanced Materials (3 papers). The work is most often cited by research in Biochemistry (54 citations), Endocrinology, Diabetes and Metabolism (144 citations), Epidemiology (234 citations), Cancer Research (83 citations) and Cardiology and Cardiovascular Medicine (147 citations). Fei Luo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiangping Li, Avash Das, Zhenfei Fang, Guiyun Ruan, Panyun Wu, Ran Peng, Yuan Guo, Jingfei Chen, Jia Peng and Federico Oldoni. Their work appears in journals such as Lipids in Health and Disease, Journal of Cellular and Molecular Medicine, World Journal of Microbiology and Biotechnology, International Journal of Cardiology and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.